1 asset in Supratentorial Cancer
Therapeutic assets addressing Supratentorial Cancer, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
Lonafarnib Supratentorial Cancer | M.D. Anderson Cancer Center | P1 | CC (43) |